Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Preceptorship on Breast Cancer 2024: Singapore

MODULE 3 - HER2+ Breast Cancer

Participant Clinical Case Discussion: Metastatic Breast Cancer ER+PR+HER2+​ Responded Well with Combination of Doublet Anti-HER2 + Chemotherapy

Date

04 Dec 2024

Session

MODULE 3 - HER2+ Breast Cancer

Topics

Targeted Therapy

Tumour Site

Breast Cancer

Presenters

Aghnia Permatasari, ID

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.